SEC Form 4 · accession 0000904454-26-000350
uniQure N.V. · QURE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Gut
Director
Period of report
Jun 10, 2026
Accepted (ET)
Jun 12, 2026 · 6:04 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001590560
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Jun 10, 2026 | M | 2,645 | $16.04 | A | 34,987 | D | |
| Ordinary SharesF2 | Jun 10, 2026 | S | 2,645 | $26.07 | D | 32,342 | D | |
| Ordinary SharesF3 | Jun 10, 2026 | S | 3,127 | $26.03 | D | 29,215 | D | |
| Ordinary SharesF4 | Jun 10, 2026 | S | 1,780 | $26.05 | D | 27,435 | D | |
| Ordinary SharesF5 | Jun 10, 2026 | A | 7,550 | $0.00 | A | 34,985 | D | |
| Ordinary SharesF6,F7 | Jun 11, 2026 | S | 2,726 | $27.06 | D | 32,259 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F8 | $16.04 | Jun 10, 2026 | M | 2,645 | D | — | Feb 24, 2032 | Ordinary Shares | 2,645 | 0 | D |
| Stock Option (Right to Buy)F9 | $26.82 | Jun 10, 2026 | A | 13,980 | A | — | Jun 10, 2036 | Ordinary Shares | 13,980 | 13,980 | D |
Explanation of responses
- F1The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on July 8, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
- F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.01 to $26.53. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote.
- F3The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.01 to $26.18. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote.
- F4The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.01 to $26.14 . The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote.
- F5Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date.
- F6The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person.
- F7The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.92 to $27.25. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote.
- F8The Stock Option vested in full on February 24, 2023.
- F9The Stock Option vests 100% on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such date.